Pharmaceutical

Boehringer Ingelheim obtains two EU CVMP positive opinions for avian influenza vaccines VAXXITEK® HVT+IBD+H5 and VAXXINACT® H5

Chickens in a barn Boehringer Ingelheim image The European Medicines Agency’s (EMA’s) Committee for Veterinary Medicinal Products (CVMP) has adopted…

1 month ago

Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Common Shares

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 20, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to…

1 month ago

Wellgistics Health Reports Third Quarter 2025 Financial Results and Provides Business Update

TAMPA, FL / ACCESS Newswire / November 20, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader…

1 month ago

Tom Brady’s 1-of-1 Game-Worn NFL Logo Patch Autograph Card Set to Breach Six Figures at Fanatics Collect Premier Auction Tonight

No Reserve | Auction Ends Tonight, Thursday, November 20, 2025 MESA, ARIZONA / ACCESS Newswire / November 20, 2025 /…

1 month ago

BioNxt Secures Final Patent Grant from the Eurasian Patent Organization for Sublingual Cladribine Platform

VANCOUVER, BC / ACCESS Newswire / November 20, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience…

1 month ago

WuXi AppTec Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition in the CRDMO Industry

WuXi AppTec sets new benchmarks in strategic execution and technological advancement, further strengthening its ability to support innovators worldwide as…

1 month ago

Peli BioThermal Welcomes John Tobin as Chief Human Resources Officer

Experienced people and transformation leader to drive global talent strategy and organizational growth MAPLE GROVE, Minn., Nov. 19, 2025 /PRNewswire/…

1 month ago

Medicure Reports Financial Results for Quarter Ended September 30, 2025

WINNIPEG, MB / ACCESS Newswire / November 19, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused…

1 month ago

NervGen Pharma Announces Closing of US$10 Million Non-Brokered Private Placement to Support Anticipated Nasdaq Listing and Advance NVG-291 Development

Vancouver, British Columbia--(Newsfile Corp. - November 19, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) ("NervGen" or the "Company"),…

1 month ago

ODAIA Adds Senior Pharma and AI Leaders to Accelerate Growth and Industry Adoption

Company expands leadership team as customer base grows and platform drives measurable commercial impact BOSTON, Nov. 19, 2025 /PRNewswire/ -- ODAIA…

1 month ago